| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |